Literature DB >> 22215714

Tonic postganglionic sympathetic inhibition induced by afferent renal nerves?

Tilmann Ditting1, Wolfgang Freisinger, Kirsten Siegel, Christian Fiedler, Lisa Small, Winfried Neuhuber, Sonja Heinlein, Peter W Reeh, Roland E Schmieder, Roland Veelken.   

Abstract

Other than efferent sympathetic innervation, the kidney has peptidergic afferent fibers expressing TRPV1 receptors and releasing substance P. We tested the hypothesis that stimulation of afferent renal nerve activity with the TRPV1 agonist capsaicin inhibits efferent renal sympathetic nerve activity tonically by a neurokinin 1 receptor-dependant mechanism. Anesthetized Sprague-Dawley rats were instrumented as follows: (1) arterial and venous catheters for recording of blood pressure and heart rate and drug administration; (2) left-sided renal arterial catheter for selective intrarenal administration of the TRPV1 agonist capsaicin (3.3, 6.6, 10, 33*10(-7) m; 10 μL; after 15, 30, 45, and 60 minutes, respectively) to stimulate afferent renal nerve activity; (3) right-sided bipolar electrode for continuous renal sympathetic nerve recording; and (4) specialized renal pelvic and renal artery catheters to separate pelvic from intrarenal afferent activity. Before and after intrarenal capsaicin application, increasing intravenous doses of the neurokinin 1 receptor blocker RP67580 were given. Intrarenal capsaicin decreased integrated renal sympathetic activity from 65.4±13.0 mV*s (baseline) to 12.8±3.2 mV*s (minimum; P<0.01). This sustained renal sympathetic inhibition reached its minimum within 70 minutes and was not directly linked to the transient electric afferent response to be expected with intrarenal capsaicin. Suppressed renal sympathetic activity transiently but completely recovered after intravenous administration of the neurokinin 1 blocker (maximum: 120.3±19.4 mV*s; P<0.01). Intrarenal afferent activity could be unequivocally separated from pelvic afferent activity. For the first time we provide direct evidence that afferent intrarenal nerves provide a tonically acting sympathoinhibitory system, which seems to be rather mediated by neurokinin release acting via neurokinin 1 receptor pathways rather than by electric afferent effects on central sympathetic outflow.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22215714     DOI: 10.1161/HYPERTENSIONAHA.111.185538

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  14 in total

Review 1.  Renal denervation: intractable hypertension and beyond.

Authors:  Wassawon Ariyanon; Huijuan Mao; Zelal Adýbelli; Silvia Romano; Mariapia Rodighiero; Bernhard Reimers; Luigi La Vecchia; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2014-01-15       Impact factor: 2.041

Review 2.  The sympathetic nervous system in chronic kidney disease.

Authors:  Sebastian Ewen; Christian Ukena; Dominik Linz; Roland E Schmieder; Michael Böhm; Felix Mahfoud
Journal:  Curr Hypertens Rep       Date:  2013-08       Impact factor: 5.369

Review 3.  Renal denervation--implications for chronic kidney disease.

Authors:  Roland Veelken; Roland E Schmieder
Journal:  Nat Rev Nephrol       Date:  2014-04-15       Impact factor: 28.314

Review 4.  Targeting neural reflex circuits in immunity to treat kidney disease.

Authors:  Mark D Okusa; Diane L Rosin; Kevin J Tracey
Journal:  Nat Rev Nephrol       Date:  2017-10-03       Impact factor: 28.314

5.  Neural regulation of the kidney function in rats with cisplatin induced renal failure.

Authors:  Niamh E Goulding; Edward J Johns
Journal:  Front Physiol       Date:  2015-06-30       Impact factor: 4.566

6.  Role of TRPV1 channels in ischemia/reperfusion-induced acute kidney injury.

Authors:  Lan Chen; Lajos Markó; Mario Kaßmann; Ye Zhu; Kaiyin Wu; Maik Gollasch
Journal:  PLoS One       Date:  2014-10-17       Impact factor: 3.240

7.  Decreased expression of TRPV1 in renal cell carcinoma: association with tumor Fuhrman grades and histopathological subtypes.

Authors:  Yong-Yang Wu; Xin-Yu Liu; De-Xiang Zhuo; Huai-Bin Huang; Fa-Biao Zhang; Shang-Fan Liao
Journal:  Cancer Manag Res       Date:  2018-06-22       Impact factor: 3.989

8.  Renal denervation in a hypertensive patient with end-stage renal disease and small arteries: a direction for future research.

Authors:  Christian Ott; Axel Schmid; Tilmann Ditting; Paul A Sobotka; Roland Veelken; Michael Uder; Roland E Schmieder
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-10-03       Impact factor: 3.738

9.  Ablation of TRPV1 Abolishes Salicylate-Induced Sympathetic Activity Suppression and Exacerbates Salicylate-Induced Renal Dysfunction in Diet-Induced Obesity.

Authors:  Beihua Zhong; Shuangtao Ma; Donna H Wang
Journal:  Cells       Date:  2021-05-18       Impact factor: 6.600

10.  Ablation of TRPV1 Elevates Nocturnal Blood Pressure in Western Diet-fed Mice.

Authors:  Beihua Zhong; Shuangtao Ma; Donna H Wang
Journal:  Curr Hypertens Rev       Date:  2019
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.